Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer.

Kurashina, Ryo; Kijima, Toshiki; Okazaki, Akihito; Fuchizawa, Hirotaka; Suzuki, Issei; Sakamoto, Kazumasa; Betsunoh, Hironori; Fukabori, Yoshitatsu; Yashi, Masahiro; Kamai, Takao

Kurashina, Ryo; Kijima, Toshiki; Okazaki, Akihito; Fuchizawa, Hirotaka; Suzuki, Issei; Sakamoto, Kazumasa; Betsunoh, Hironori; Fukabori, Yoshitatsu; Yashi, Masahiro; Kamai, Takao.

Afiliação

Kurashina R; Department of Urology Dokkyo Medical University Tochigi Japan.
Kijima T; Department of Urology Dokkyo Medical University Tochigi Japan.
Okazaki A; Department of Urology Dokkyo Medical University Tochigi Japan.
Fuchizawa H; Department of Urology Dokkyo Medical University Tochigi Japan.
Suzuki I; Department of Urology Dokkyo Medical University Tochigi Japan.
Sakamoto K; Department of Urology Dokkyo Medical University Tochigi Japan.
Betsunoh H; Department of Urology Dokkyo Medical University Tochigi Japan.
Fukabori Y; Department of Urology Dokkyo Medical University Tochigi Japan.
Yashi M; Department of Urology Dokkyo Medical University Tochigi Japan.
Kamai T; Department of Urology Dokkyo Medical University Tochigi Japan.

IJU Case Rep ; 4(2): 69-73, 2021 Mar.

Article em En | MEDLINE | ID: mdl-33718807

Palavras-chave

chemotherapy; diffusionweighted magnetic resonance imaging; neuroendocrine tumors; prostate cancer; prostatespecific antigen

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: IJU Case Rep Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: IJU Case Rep Ano de publicação: 2021 Tipo de documento: Article